Immunohistochemistry analysis of brains from AD (Alzheimer ́s disease) patients suggests a blockage of Nrf2 nuclear translocation and, consequently, lower Nrf2 transcriptional activity7. Here, NFE2L2 is linked to Alzheimer disease.